Pfizer Inc.
PFE
$26.08
$0.140.54%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2024 | 09/29/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 0.36% | 33.26% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.36% | 33.26% | |||
| Cost of Revenue | 17.88% | 75.98% | |||
| Gross Profit | -6.30% | 22.02% | |||
| SG&A Expenses | 52.02% | -12.40% | |||
| Depreciation & Amortization | 3.58% | 0.38% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 25.92% | 15.10% | |||
| Operating Income | -51.60% | 96.20% | |||
| Income Before Tax | -100.21% | 4,677.67% | |||
| Income Tax Expenses | -279.91% | 274.63% | |||
| Earnings from Continuing Operations | -90.83% | 14,354.84% | |||
| Earnings from Discontinued Operations | 187.50% | -147.06% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 0.00% | -14.29% | |||
| Net Income | -90.82% | 10,790.24% | |||
| EBIT | -51.60% | 96.20% | |||
| EBITDA | -39.17% | 61.29% | |||
| EPS Basic | -90.82% | 10,843.06% | |||
| Normalized Basic EPS | -38.17% | 103.70% | |||
| EPS Diluted | -90.94% | 10,843.06% | |||
| Normalized Diluted EPS | -38.15% | 103.36% | |||
| Average Basic Shares Outstanding | 0.00% | 0.02% | |||
| Average Diluted Shares Outstanding | -0.04% | 0.16% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 9.89% | -0.99% | |||
